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ABSTRACT
Adenomatoid odontogenic tumor (AOT) is a relatively rare benign, epithelial tumor of odontogenic origin. There is varying class of thoughts 
contemplating this lesion to be a hamartoma or neoplastic growth of odontogenic epithelium. Controversy regarding the histogenesis of the lesion is 
plentiful in earlier literature. The recent advent of immunohistochemical and ultrastructural studies has aided in throwing light on the tissue of origin 
of this tumor. This review aims at understanding the evolving concepts of histogenesis of AOT to better understand the biological behavior of the 
lesion. The review of AOT was carried out using PubMed and Google Scholar databases and 39 articles from the year 2001 to 2016 which contributed 
to the histogenesis of AOT were included for review. Since the origin of the cystic lining is similar to a reduced enamel epithelium and not the dental 
lamina, we propose the former to be the progenitor of AOT. Furthermore, we consider extra-follicular, as well as peripheral AOTs, originate from the 
remnants of Hertwig’s epithelial root sheath (epithelial rests of Malassez), which complies with the common histology for all these variants.
Keywords: Adenomatoid odontogenic tumor, Odontogenic tumor, Histogenesis.
INTRODUCTION
Odontogenic tumors are defined as a spectrum of lesions ranging 
from benign and malignant neoplasms to dental hamartomas; formed 
generally in the same sequence as in normal tooth development and 
all arising from dental remnants, that is, derived either from epithelial, 
ectomesenchymal and/or mesenchymal elements of the tooth-
forming apparatus [1]. Knowledge of the basic elementary characters 
of different odontogenic tumors such as site of occurrence, age 
distribution and radiographic appearance is important in arriving at a 
clinical differential diagnosis [2,3]. Odontogenic tumors like any other 
neoplasm can mimic its cell of origin histologically [2,4]. The epithelium 
contributing to odontogenic tumor may be derived from the pre/post 
functional dental lamina, basal cell layer of the gingival epithelium, 
dental papilla/follicle, and remnants in the periodontal ligaments [5,6].
Adenomatoid odontogenic tumor (AOT) is a relatively rare, deviant, 
hamartomatous, benign, epithelial lesion of odontogenic origin [7], and 
constitutes about 2–7% of odontogenic cysts and tumors combined [5]. 
The WHO classification of odontogenic tumors has defined AOT as being 
comprised of odontogenic epithelium in an array of histoarchitectural 
patterns, embedded in mature connective tissue stroma, and characterized 
by gradual but progressive growth [8] with generally no tendency of 
recurrence. AOT is generally intraosseous, primarily in the anterior 
maxilla; the lower and upper canine area has more affinity to this lesion; 
however, it can also be seen in peripheral locations. More commonly seen 
in young patients, females are affected twice as commonly as males with a 
ratio of 1:1.9 [9]. AOT is a non-invasive tumor and recurrence rate is very 
low [10]. Different types or variants of AOT are central (or intraosseous) 
variants which are further divided into follicular (or pericoronal) type 
and extrafollicular (or extracoronal) type and the peripheral (or gingival) 
variant (PAOT) [11]. AOT could remain intraosseous or peripheral in the 
jaw bones, depending on the spatial position of the tumor and associated 
tooth. In deeper impacted teeth, there would be more possibility of AOT to 
be intraosseous follicular or extrafollicular (in the case of tooth eruption) 
lesion. In tooth impactions next to the alveolar ridge, the tumor could 
occasionally involve the gingiva during or after the eruption process, 
which would justify the peripheral variant [12,13].
The review of AOT was carried out using PubMed and Google Scholar 
databases. The keywords used were (AOT, histogenesis, odontogenic 
tumors, and histology) and all articles were taken for initial evaluation. 
Review articles on AOT and case reports on other odontogenic tumors other 
than AOT were excluded from the search. We also excluded clinical trials 
and animal research. In the present review, we studied the following 39 
articles from the year 2001 to 2016 which contributed to the histogenesis 
of AOT were included for review (Table 1) [8,12,14-19,25-32,35-51]. The 
earlier articles were excluded since no significant research on histogenesis 
was available before this year, and earlier concepts were already 
addressed in articles included for this study. The purpose of this review 
was to delineate the clinical, histopathological, and immunohistochemical 
(IHC) profile of AOT to aid its diagnosis and alleviate confusion between 
other tumors in this category.
There are legitimate reasons for characterizing and renaming an 
entity, and foremost among these is when it can be established that 
it behaves and can be managed differently from other members 
of its original group. In most cases, it will be recognized as having 
distinguishable histopathological features also [33]. Thus, it becomes 
a new clinicopathological entity. The extensive review of literature of 
AOT has been enlisted in Table 1. This was how the AOT emerged from 
the then variants of ameloblastomas [34].
WHY AOT WAS CLASSIFIED AS EPITHELIAL TUMOR?
Based on the classification of odontogenic tumors that are based on 
the inductive influences between epithelial and mesenchymal tissues 
during odontogenesis, AOT has been included in the epithelial category 
rather than the mixed group, despite the presence of abnormal hard 
tissue elements within the tumor [52,53]. This was supported in a 
recent IHC study that used bone morphogenetic protein (BMP) to 
divide odontogenic tumors into those that were purely epithelial 
(i.e., negative for BMP) and those that formed hard tissue (i.e., positive 
for BMP) [54]. The epithelial component of this tumor is cellular where 
the pre-ameloblast like cells are arranged radially with interspersing 
spindle-shaped cells in some areas, whereas the other areas show 
epithelial cells which are arranged in interlacing strands resembling 
that of plexiform ameloblastomas [55,56].
Hamartoma or neoplasm
There is two class of thought, while some contemplate this lesion as a 
developmental outgrowth or hamartoma, other groups account them 
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A molecular study by Razavi et al. showed that the Ki-67 labeling index 
was lower in AOTs as compared to SMAs, signifying a hamartomatous 
nature [58]. However, using a human androgen receptor gene 
polymorphism assay, Gomes et al. found that AOTs are monoclonal 
and, therefore, neoplastic [59]. Certain characters or features of AOT 
which suggest it to be true neoplasm or hamartoma as stated by various 
authors
Hamartoma
In 2004, Rick stated that the limited size of AOT, its minimal growth 
potential, and the lack of recurrence even after incomplete removal 
attributed to its hamartomatous nature [6]. Low expression of BCL2 
and Ki67 activity compared to ameloblastoma [58]. Medeiros et al. 
in 2005 conducted a study where they used proliferating cell nuclear 
antigen (marker for mitosis activity) and P53 (marker that indicates 
proliferative and anti-apoptotic activities) in AOT cases and found that 
IHC markers were very low thus they stated AOT as hamartoma rather 
than tumor [58,64]
Electron microscopic studies of duct-like structures formed within 
the tumor revealed the presence of hemidesmosomal junctions and 
evidence of basal lamina at the luminal pole of these cells. They also 
show secretory granules and coated vesicles near the luminal pole 
which are suggestive of a morphology similar to pre-ameloblasts. The 
eosinophilic material coexpressed basement membrane extracellular 
matrix proteins such as laminin, type IV collagen, heparin sulfate 
proteoglycan, fibronectin, and also enamel matrix proteins [71,72]. 
Furthermore, these cells are negative reactivity of these cells to 
lactoferrin and a1-antichymotrypsin anti-bodies which rule out 
glandular origin [14].
The non-duct-forming columnar cells expressed amelogenin reactivity, 
whereas the duct-forming cells showed no reactivity to amelogenin [71] 
or the other enamel matrix protein (enamelin and sheathlin) 
antibodies [73-75]. The ultrastructural studies show that the small, 
irregular calcifications may be partially composed of atypical enamel 
is supported by its positive reactivity to amelogenin, enamelin, and 
enamelysin although it is indistinguishable from calcified amyloid [76].
The epithelial tumor cells display features that are consistent with 
neoplastic (pre)ameloblasts in a state of arrested development [77]. 
The ameloblasts are yet metabolically active enough to produce 







































































































































































































































































































































































































































































































































































































































































































































































































































































as a neoplastic growth of odontogenic epithelium. Glickman et
 al.  drew  an  inference  by  saying  that  “such  a  controversy  is 
irresolvable because sound arguments can be advanced in favor of and 
against both hypotheses.  The arguments are based on personal bias 
rather than on scientific evidence” [8,57].
Neoplasm
Small  size and probable early  detection and it’s  removable 
before  this  slow-growing  neoplasm  reach  considerable  size  [9]. 
Microscopic  features  show  the  greater  difference  from 
normal  odontogenic  apparatus  than  would  have  seen  in  a 
developmental  anomaly  [54].  It  has  been  stated  that  many  cases 
have gone undetected and untreated for many years due to their
 size  and  ultimately  resulted  in  facial  asymmetry  and 
distortion. Using a human androgen receptor gene polymorphism
 assay,  Gomes  et  al.  found  that  AOTs  are  monoclonal  and,  therefore, 
neoplastic [60-63].
Histogenesis of AOT
The  origin  of  AOT  is  from  the  odontogenic  epithelium;  this  fact  is 
well established; however, the progenitor cell or tissue is not yet settled
 and  still  under  discussion.  The  suggested  cells  by  various  authors  are 
enamel  organ  [65,66],  reduced  enamel  epithelium  (REE)  [67], 
undifferentiated odontogenic epithelium or stratum intermedium 
cells [68],  stratum intermedium cells [69,70],  and dental lamina and 
its remains (Philipsen and Reichart, 1999, Philipsen et al., 1992) [15].
60
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that the accumulation and subsequent degradation of these enamel 
secretory products by enzymes such as enamelysin are responsible 
for the development of the duct-like structures [71]. These structures 
are in fact enclosed spherical microcysts and their nature whether 
completely intraepithelial or stromal is debatable [79].
The tumor may be partly cystic, and in some cases, the solid lesion 
may be present only as masses in the wall of a large cyst. It is generally 
believed that the lesion is not a neoplasm [80,81].
Although the definition states that the lesion may have a cystic 
nature, very few case reports have described the cystic lining. Cystic 
presentation of AOT has been reported way back in 1915 by Harbitz 
who reported the lesion as “cystic adamantoma” [82].
Philipsen et al. have strongly argued in favor of the concept of AOT 
being derived from the complex system of the dental lamina or its 
remnants [11]. Marx and Stern considered AOT as a cyst and not a 
tumor and further gave a new terminology for this lesion, “adenomatoid 
odontogenic cyst (AOC).” Marx and Stern proposed that AOTs should 
not be considered tumors but cysts with a hamartomatous intraluminal 
proliferation of epithelial cells derived from the Hertwig’s epithelial 
r1ot sheath (HERS) [9]. However, Rick stated that AOTs were benign 
embryonal neoplasms; he disagreed with the change in terminology as 
the majority of lesions have a predominantly solid component instead 
of a fluid-filled cavity. According to Marx and Stern, the AOC does not 
arise from the follicle of the tooth crown but instead arises from HERS, 
which would explain the finding of the tooth being completely within 
the lumen rather than the tooth root being within a bony crypt.
Considering all the case reports of AOT associated with dentigerous cyst, 
it is very much evident that the tumor is originating from the cystic lining. 
Moreover, the WHO definition of AOT given by Philipsen et al. supports 
this fact of cystic lining to be the progenitor for tumor in many cases. 
Since the origin of the cystic lining in the dentigerous cyst is REE and not 
the dental lamina, we propose the former to be the progenitor of AOT.
IHC, it has been shown that the immunophenotypic profile of REE 
and AOT epithelium is virtually identical [83]. The expression of 
CK14 and the ultrastructural aspects of the AOT probably indicated 
its origin in the reduced dental epithelium [83]. Where CK14 showed 
expression in the cells which were between the spindled and duct-
like structures, these structures formed a cell group comparable to 
post-secretory ameloblasts of the REE, which was surrounded by a 
second group, composed of flat fusiform cells, which was similar to 
that of stellate reticulum. This justifies the expression in all epithelial 
cell elements of other AOTs and the REE, regardless of the histological 
characteristics [15]. Laminin was clearly present in the luminal surface 
of the adenomatoid structures and the lighter eosinophilic intercellular 
deposits, either focal or linear, which is compatible with the surface 
of the REE during the protective stage of amelogenesis. Nevertheless, 
the authors believed that some cells of AOT (cribriform areas) would 
resemble dental lamina (primitive cell), while others would represent 
histodifferentially more mature secretory phase of odontogenesis [15].
CONCLUSION
In classical AOT (solid), the proliferation of nodules originating from 
the cystic lining fills up the entire lumen whereas in cystic variant 
this process is incomplete and is thus seen only in parts of the cystic 
lining. Since the origin of the cystic lining is similar to a REE and not 
the dental lamina, we propose the former to be the progenitor of AOT. 
Furthermore, we consider extra-follicular, as well as peripheral AOTs, 
originate from the remnants of HERS (epithelial rests of Malassez), 
which complies with the common histology for all these variants [28]
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